Formulary Chapter 5: Infections - Full Chapter
|
|
Chapter Links... |
NICE NG199: Clostridioides difficile infection: antimicrobial prescribing |
NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use |
NICE NG79: Sinusitis (acute): antimicrobial prescribing |
NICE NG79: Sinusitis (acute): antimicrobial prescribing (visual summary) |
Summary of antimicrobial prescribing guidance - managing common infections |
Details... |
05.01.07 |
Some other antibacterials |
|
|
Nitazoxanide (Alinia®) (Oral powder for reconstitution to suspension, Tablet)
|
Restricted
|
For Hospital Use Only
|
|
Bedaquiline
|
Formulary
|
Hospital use only under microbiological and Tuberculosis specialist advice
|
|
Dalbavancin
|
Restricted
|
Hospital use only under microbiological advice
|
|
05.01.07 |
Chloramphenicol |
|
|
Chloramphenicol (Oral and injection)
|
Formulary
|
For specialist use only
|
|
05.01.07 |
Fosfomycin |
|
|
05.01.07 |
Fusidic acid |
|
|
Fusidic acid (Tablet, oral suspension)
|
Formulary
|
|
|
Sodium fusidate (IV Infusion)
|
Formulary
|
|
|
Sodium fusidate (Tablets)
|
Formulary
|
|
|
05.01.07 |
Vancomycin and teicoplanin |
|
|
Teicoplanin (Oral ,IV and injection)
|
Formulary
|
For hospital use only
|
|
Vancomycin (Capsules)
|
Formulary
|
|
|
Vancomycin (Injection)
|
Formulary
|
|
|
05.01.07 |
Daptomycin |
|
|
Daptomycin (injection)
|
Formulary
|
Hospital use only under microbiological advice
|
|
05.01.07 |
Linezolid |
|
|
Linezolid (Oral formulations)
|
Formulary
|
For hospital use only
|
|
Linezolid (infusion)
|
Formulary
|
For hospital use only
|
|
05.01.07 |
Quinupristin and dalfopristin |
|
|
05.01.07 |
Polymyxins |
|
|
Colistimethate (Injection)
|
Formulary
|
Hospital use only under microbiological advice
|
|
Colistimethate (Promixin®)
|
Formulary
|
|
|
Colistimethate for nebulisation
|
Formulary
|
|
|
Colistimethate for nebulisation (Colomycin®)
|
Formulary
|
|
|
Colistimethate inhaler (Colobreathe®)
|
Formulary
|
|
|
05.01.07 |
Rifaximin |
|
|
Rifaximin (oral presentations)
|
Formulary
|
|
NICE TA 337 :Rifaximin for preventing episodes of overt hepatic encephalopathy
|
05.01.07 |
Fidaxomicin |
|
|
Fidaxomicin (Tablets)
|
Formulary
|
On Microbiological advice only
|
|
.... |
Non Formulary Items |
Daptomycin (Cubicin®)
|
Non Formulary
|
|
|
Fidaxomicin (Dificlir®)
|
Non Formulary
|
|
|
Linezolid (Zyvox®)
|
Non Formulary
|
|
|
Quinupristin and dalfopristin (Synercid®) (injection)
|
Non Formulary
|
|
|
|
Key |
|
Restricted Drug |
|
Unlicensed |
|
Link to adult BNF
|
|
Link to children's BNF
|
|
Link to SPCs
|
|
Cytotoxic Drug |
|
Controlled Drug |
|
|
High Cost Medicine |
|
Cancer Drugs Fund |
|
NHS England |
|
Homecare |
|
ICB |
|
Low carbon footprint |
|
Medium carbon footprint |
|
High carbon footprint |
|
Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications |
|
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry. |
|
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry. |
|
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist. |
|
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only |
|
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information. |
|
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use. |
|
Check Notes as varies across the area |
|
|
|